Subjects with NAFLD and hs-CRP levels below the median were more obese and showed worse metabolic profiles compared with those without NAFLD and hs-CRP levels above the median (Table 3). The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.